ARDX · Ardelyx, Inc.
$3.82
-0.01 (-0.26%)
At close · Aug 27
Market Cap
$954.39M
Shares
249.19M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $7,796,171 |
| Edward Conner | Former Chief Medical Officer | $3,623,910 |
| Justin Renz | Former Chief Financial and Operations Officer | $3,551,684 |
| Susan Hohenleitner | Chief Financial Officer | $3,437,372 |
| John Bishop | Chief Technical and Quality Officer | $2,512,522 |
| Elizabeth Grammer | Former Chief Legal and Administrative Officer | $2,303,617 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $9,606,165 |
| Michael Kelliher | EVP, Corporate Development and Strategy | $2,990,924 |
| Justin Renz | Chief Financial and Operations Officer | $2,983,853 |
| Elizabeth Grammer | Chief Legal and Administrative Officer | $2,973,306 |
| Laura Williams | M.D., M.P.H. Chief Medical Officer | $2,827,381 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $4,118,144 |
| Elizabeth Grammer | Chief Legal and Administrative Officer | $1,630,871 |
| Laura Williams | M.D., M.P.H. Chief Medical Officer | $1,627,431 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $1,947,020 |
| Laura Williams | M.D., M.P.H. Chief Medical Officer | $1,055,211 |
| Susan Rodriguez | Chief Commercial Officer | $1,044,389 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $4,230,994 |
| Justin Renz | Chief Financial Officer | $1,734,063 |
| Elizabeth Grammer | Chief Legal and Administrative Officer | $1,734,063 |
| Robert Blanks | Chief Regulatory Affairs and Quality Assurance Officer | $1,701,163 |
| David Rosenbaum | Chief Development Officer | $1,630,763 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $3,953,984 |
| Susan Rodriguez | Chief Commercial Officer | $1,822,796 |
| Justin Renz | Chief Financial Officer | $1,468,247 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President, Chief Executive Officer and Director | $1,728,922 |
| David Rosenbaum | Chief Development Officer | $812,658 |
| Elizabeth Grammer | Chief Legal and Administrative Officer | $791,408 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Michael Raab | President & Chief Executive Officer | $4,182,246 |
| David Rosenbaum | Chief Development Officer | $1,711,796 |
| Elizabeth Grammer | Chief Legal and Administrative Officer | $1,694,156 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard Rodgers | Class III Director | Appointed | 2026-06-17 |
| Muna Bhanji, R.Ph | Class III Director | Appointed | 2026-06-17 |
| Robert Bazemore | Class III Director | Appointed | 2026-06-17 |
| Laura Williams | interim Chief Medical Officer | Appointed | 2025-12-17 |
| Edward Conner | Chief Medical Officer | Resigned | 2025-12-17 |
| Sue Hohenleitner | chief financial officer ("CFO") and principal financial officer | Appointed | 2025-10-14 |
| James P. Brady | Chief Human Resources Officer | Appointed | 2025-08-04 |
| Mike Kelliher | Chief Business Officer | Appointed | 2025-08-04 |
| Michael Raab | Class II Director | Appointed | 2025-06-18 |
| David Mott | Class II Director | Appointed | 2025-06-18 |
| Merdad Parsey, M.D., Ph.D | member of the Board of Directors | Appointed | 2025-04-29 |
| Joseph Reilly | Principal Accounting Officer | Appointed | 2024-11-18 |
| Onaiza Cadoret-Manier | Class I Director | Appointed | 2024-06-17 |
| William A. Bertrand, Jr., Esq. | Class I Director | Appointed | 2024-06-17 |
| Geoffrey A. Block, M.D. | Board of Directors | Resigned | 2023-11-13 |
| Robert Felsch | Chief Accounting Officer | Appointed | 2022-03-14 |
| William Bertrand, Jr., Esq. | Chairman of the Nominating and Governance Committee | Appointed | 2021-03-15 |
| Muna Bhanji | member of the Nominating and Governance Committee of the Board | Appointed | 2021-03-15 |
| Muna Bhanji | member of the Board | Appointed | 2021-03-15 |
| Gordon Ringold, Ph.D. | member of the Board, and the Nominating and Governance Committee of the Board, of which he served as Chairman | Resigned | 2021-03-15 |
| Justin Renz | Chief Accounting and Principal Financial Officer | Appointed | 2020-06-10 |
| Keith Santorelli | acting principal financial and accounting officer | Appointed | 2020-03-17 |
| Onaiza Cadoret-Manier | member of the Nominating and Governance Committee of the Board | Appointed | 2020-03-17 |
| Onaiza Cadoret-Manier | member of the Board | Appointed | 2020-03-17 |
| Annalisa Jenkins, M.B.B.S., F.R.C.P. | member of the Board, the Audit Committee of the Board and the Nominating and Governance Committee of the Board | Resigned | 2020-03-17 |
Key facts
CIK
1437402
CUSIP
039697107
13F (30d)
218 filings
214 filers
Visit website
Investor relations